Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers.
about
Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survivalThe metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and metastatic pathways.Whole-genome methylation analysis of benign and malignant colorectal tumoursPromoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequenceEpigenetic Biomarkers in Colorectal Cancer.Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics dataDNA demethylation in normal colon tissue predicts predisposition to multiple cancers.Epigenetic Pathways in Human Disease: The Impact of DNA Methylation on Stress-Related Pathogenesis and Current Challenges in Biomarker Development.Colorectal advanced neoplasms occur through dual carcinogenesis pathways in individuals with coexisting serrated polyps.CRABP1 provides high malignancy of transformed mesenchymal cells and contributes to the pathogenesis of mesenchymal and neuroendocrine tumors.A comprehensive look at transcription factor gene expression changes in colorectal adenomas.Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors.KISS1 methylation and expression as predictors of disease progression in colorectal cancer patientsADAM and ADAMTS family proteins and their role in the colorectal cancer etiopathogenesis.Novel methylation biomarker panel for the early detection of pancreatic cancer.Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinomaA study of genomic instability in early preneoplastic colonic lesions.RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular featuresTargeted re-sequencing identified rs3106189 at the 5' UTR of TAPBP and rs1052918 at the 3' UTR of TCF3 to be associated with the overall survival of colorectal cancer patients.NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva.Expression of RUNX3 and β-catenin in the carcinogenesis of sporadic colorectal tubular adenoma.Aberrant promoter methylation of HIN-1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.DNA methylation ratio variability may impede clinical application of cancer diagnostic markers.Repeated anastomotic recurrence of colorectal tumors: genetic analysis of two cases.Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis.Downregulation of A disintegrin and metallopeptidase with thrombospondin motif type 1 by DNA hypermethylation in human gastric cancer.Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning.Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia.LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer.The significance of epigenetic alterations in lung carcinogenesis.Correlation of MLH1 and MGMT methylation levels between peripheral blood leukocytes and colorectal tissue DNA samples in colorectal cancer patients.Toward a comprehensive and systematic methylome signature in colorectal cancers.The Effect of Sex on the Azoxymethane/Dextran Sulfate Sodium-treated Mice Model of Colon Cancer.RUNX3 is multifunctional in carcinogenesis of multiple solid tumors.Oncogenic role of RUNX3 in head and neck cancer.The RUNX family in breast cancer: relationships with estrogen signaling.Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: a meta-analysis
P2860
Q24626799-8354431C-A2E8-4175-9B50-1F7E512B3066Q27687896-EF578D3D-CC5E-4183-9570-FAC07F8F2587Q28109367-F71E41DA-7BCF-4759-877E-5ADD12D07D82Q28241736-0980052C-DE6D-41E0-9ECC-BCCD946C04F0Q30240778-A2CF5F07-8A11-4076-9AEB-15664979FF9AQ30956148-0EEA892D-85A0-43EB-BFE4-C905F233DE48Q33581249-1F42C5F8-C479-4786-B5FC-D178C05C69B3Q33603731-1C34C9EE-4B80-42D8-8354-BE2383A48C8BQ33645406-15B59CD0-8A10-4F2E-89B2-535C435E7976Q33728933-FDC18BD8-B4C9-46B2-9C2B-0C7572A3D27DQ33831794-5BDA3017-3FA2-431D-927F-A945D81940AEQ33892398-2A026D63-CAC4-44DB-AA04-744B1BB5AEDCQ33942280-E70F4AE5-C7E4-4881-AC74-D166AA111622Q34008651-D3CBBEB4-2A68-49C6-A820-386B6C1E4F83Q34049378-7ACB38E5-B9B8-4C94-8DE5-04EDF72275B8Q34374959-9B943D2B-7C48-4123-8E0C-CE598C27319DQ34410542-77AB93D9-8DEA-4353-9D26-81CA3A5A6D26Q34486212-C92CB1D1-7AB6-455B-B720-2441409B0B76Q34514570-C349A974-4C02-481B-B722-681A174364DFQ34606632-7292F2EA-AE07-43E4-A574-4D46D5480BC8Q34650716-8444D04A-5018-4E0E-AC6E-CA2BF11C7440Q34934917-72C2886C-01D0-462B-B36C-38C09B1D5829Q35091263-71B409C0-37DD-4110-83E1-4584E4FE165BQ35119181-A55BC14A-C34F-4465-8134-9083AA6C1CB7Q35172269-31D1678F-BE41-48A2-BBD2-7F83BB6A30B1Q35191841-E8A500B4-9E42-40E2-AE26-27EB49282C1BQ35236001-2C507AC7-9AA0-49CC-B03F-19F473674A9FQ35567859-409088F1-1100-45F5-9C74-11D743611162Q35728951-9C7FC5CA-4DD8-4516-B74D-9F52FAF9D09CQ36296760-9794AE68-DD2C-4751-A749-A19872167B0AQ36359503-3BC2EC24-33D1-4D28-9316-9DEC97B0EDF6Q36414307-132A10AC-C263-4840-B440-0C2BB4A4DE43Q36457427-14F313AC-BF07-4B21-890A-7C53CD17E7EDQ37269557-2F72DB3E-F687-49E7-90F8-78EF1DB0E98BQ37445275-ED1DC0E6-143C-4AE4-9BC5-EAFFFF381011Q37552326-39D30570-94E2-4FB1-9A2E-82BBBFABF0C8Q37720402-FCD99E96-C15E-47D4-AAAF-07D633DD0784Q37832454-516F8D7F-98B2-4B40-80E7-8598F0815659Q38050410-AE7492A1-217C-48E7-BB65-4EA996C1E9FBQ38233031-B02E241E-7D97-49E2-B5CF-0E6016FB831E
P2860
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene methylation profiles of n ...... identify early onset markers.
@en
Gene methylation profiles of n ...... identify early onset markers.
@nl
type
label
Gene methylation profiles of n ...... identify early onset markers.
@en
Gene methylation profiles of n ...... identify early onset markers.
@nl
prefLabel
Gene methylation profiles of n ...... identify early onset markers.
@en
Gene methylation profiles of n ...... identify early onset markers.
@nl
P2093
P2860
P50
P356
P1433
P1476
Gene methylation profiles of n ...... identify early onset markers.
@en
P2093
Espen Thiis-Evensen
Geir S Hoff
Gunn I Meling
Guro E Lind
Terje Ahlquist
Torleiv O Rognum
Vera L Costa
P2860
P2888
P356
10.1186/1476-4598-7-94
P577
2008-12-31T00:00:00Z
P5875
P6179
1051762171